Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)

Ongoing biomarker development programs have been designed to identify serologic or imaging signatures of clinico-pathologic entities, assuming distinct biological boundaries between them. Identified putative biomarkers have exhibited large variability and inconsistency between cohorts, and remain in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturchio, Andrea, Marsili, Luca, Vizcarra, Joaquin A., Dwivedi, Alok K., Kauffman, Marcelo A., Duker, Andrew P., Lu, Peixin, Pauciulo, Michael W., Wissel, Benjamin D., Hill, Emily J., Stecher, Benjamin, Keeling, Elizabeth G., Vagal, Achala S., Wang, Lily, Haslam, David B., Robson, Matthew J., Tanner, Caroline M., Hagey, Daniel W., El Andaloussi, Samir, Ezzat, Kariem, Fleming, Ronan M. T., Lu, Long J., Little, Max A., Espay, Alberto J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578373/
https://www.ncbi.nlm.nih.gov/pubmed/33132895
http://dx.doi.org/10.3389/fnagi.2020.553635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578373/
https://www.ncbi.nlm.nih.gov/pubmed/33132895
http://dx.doi.org/10.3389/fnagi.2020.553635

Ejemplares similares